Mallinckrodt Pharma IP Trading D.A.C.
USPTO PatentsView assignee record - 12 granted patents across 12 technology areas, recorded in grant years 2016–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Mallinckrodt ranks #22,936 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 12 technology areas.
- #22,936
- of 49,997 US assignees by volume
- 37th percentile
- by Innovation Score (31.3/100)
- 16.9
- avg claims per patent
- -91%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R22936 · Foreign Corporation #22,936 · 12 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 12 grants
- MID-PACK #22,936/49,997
- PHOTO-FINISH Maco Pharma
- CPC-FOCUS A61P · 12 areas
- INNOV-THIN 31.3/100
- CLAIMS-RICH 16.9 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DROP -91% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Maco Pharma (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Mallinckrodt’s 31.3 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Mallinckrodt
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Textnow · near 31
Textnow · near
31 score
- IonSense · near 31
IonSense · near
31 score
- Mallinckrodt Pharma… · this assignee 31
Mallinckrodt Pharma… · this assignee
31 score
- Nippon Sharyo · near 31
Nippon Sharyo · near
31 score
- Tintri by DDN · near 31
Tintri by DDN · near
31 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Mallinckrodt's Innovation Score is 31.3/100 (37th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Mallinckrodt?
Each dot is one of Mallinckrodt’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Mallinckrodt’s own 16.9 claims/patent is ABOVE the 16.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Mallinckrodt's grants concentrate
Mallinckrodt Pharma IP Trading D.A.C. is a focused PatentsView assignee: 12 CPC subclasses with 58.3% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2017 (6 grants) versus a trough of 1 in 2016. By volume, Mallinckrodt sits between Maco Pharma and Mantle Inc..
Who files at Mallinckrodt's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Maco Pharma
Maco Pharma
12 patents
- Magna Mirrors Hol…
Magna Mirrors Holding GmbH
12 patents
- Magneco/Metrel
Magneco/Metrel, Inc.
12 patents
- Mainetti
Mainetti GmbH
12 patents
- Manageiq
ManageIQ, Inc.
12 patents
- Maniff Creations
Maniff Creations, Inc.
12 patents
- Manta Devices
Manta Devices, LLC
12 patents
- Mantle
Mantle Inc.
12 patents
- Mallinckrodt Phar… ◀
Mallinckrodt Pharma IP Trading D.A.C.
12 patents
What this shows Mallinckrodt holds 12 patents at rank #22,978, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Mallinckrodt
By rank, the assignees closest to #22,978 in granted patent volume.
- Maco Pharma #22,974 · 12 patents
- Magna Mirrors Holding GmbH #22,975 · 12 patents
- Magneco/Metrel, Inc. #22,976 · 12 patents
- Mainetti GmbH #22,977 · 12 patents
- ManageIQ, Inc. #22,979 · 12 patents
- Maniff Creations, Inc. #22,980 · 12 patents
- Manta Devices, LLC #22,981 · 12 patents
- Mantle Inc. #22,982 · 12 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Mallinckrodt's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Mallinckrodt, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Mallinckrodt ranks #2,588 of 6,058 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (31 here).
Mallinckrodt's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
31 37th percentile higher than 37% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 8.3% |
| 2017 | 6 | 50.0% |
| 2018 | 3 | 25.0% |
| 2019 | 1 | 8.3% |
| 2020 | 1 | 8.3% |
Which technologies does Mallinckrodt Pharma IP Trading D.A.C. patent most?
Top 12 of 12 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Mallinckrodt Pharma IP Trading D.A.C.'s patent record in context - here's where to go next.
- Mallinckrodt Pharma IP Trading D.A.C.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 58.3% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #22,936 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Mallinckrodt Pharma IP Trading D.A.C. against Maco Pharma, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 31.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.